The antibiotic resistance market is driven by the rising prevalence of multidrug-resistant infections, increasing demand for novel antimicrobials, and advancements in rapid diagnostics. North America ...

The discovery of a new preclinical compound with strong antifungal activity against multidrug-resistant pathogens is described in Nature. The drug, named mandimycin, is a member of a known family of ...

They're being warned that "people may be sick for months before receiving a diagnosis, which can lengthen exposure periods" ...

A new national cohort study provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The ...

Fungal infections caused by Candida species pose a growing threat to global health, particularly in immunocompromised and critically ill patients. The rise ...

War, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of ...

Candida auris has emerged as a formidable global health threat, largely due to its propensity for multidrug resistance and hospital-acquired transmission. This fungal pathogen challenges conventional ...

Federal health officials are investigating a multi-state outbreak of Salmonella Saintpaul infections linked to backyard poultry, with some cases showing signs of resistance to multiple antibiotics. At ...

Multidrug resistance in Gram-negative bacteria represents a major public health challenge, with these organisms evolving a myriad of mechanisms to evade the effects of antibiotic treatment. One ...

A new class of antibiotics has demonstrated fast-acting, potent activity against two of the WHO’s priority pathogens. Researchers from the University of Liverpool (UK) have developed NovItex, a new ...

A long-term study shows MDR-TB treatment success is underestimated, with most patients remaining relapse-free, highlighting ...

A traditional medicinal plant, tormentil, shows promise against antibiotic-resistant bacteria in laboratory tests. Its ...